Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder

BJU International

Volumn 103, Issue 5, 2009, Pages 694-697

  Watson, Jenny A ^a,b   Burling, Keith ^c   Fitzpatrick, Patricia ^b   Kay, Elaine ^d   Kelly, John ^e   Fitzpatrick, John M ^f   Dervan, Peter A ^f   McCann, Amanda ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d BEAUMONT HOSPITAL   (Ireland)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Biomarker; ELISA; Genomic imprinting; Insulin like growth factor 2 (IGF 2); Urothelial carcinoma of the bladder (UCB)

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; SOMATOMEDIN B;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; CYSTOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE LEVEL;

EID: 60449098195     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08213.x     Document Type: Article

References (25)

1. O'Dell SD, Day IN. Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 1998 30 : 767 71
2. Nolan CM, Kyle JW, Watanabe H, Sly WS. Binding of insulin-like growth factor II (IGF-II) by human cation-independent mannose 6-phosphate receptor/IGF-II receptor expressed in receptor-deficient mouse L cells. Cell Regul 1990 1 : 197 213
3. Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 2005 142 : 44 52
4. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993 362 : 747 9
5. McCann AH, Miller N, O'Meara A et al. Biallelic expression of the IGF2 gene in human breast disease. Hum Mol Genet 1996 5 : 1123 7
6. Tricoli JV, Rall LB, Karakousis CP et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986 46 : 6169 73
7. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS, Plymate SR. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 1996 81 : 3774 82
8. Sayer RA, Lancaster JM, Pittman J et al. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol Oncol 2005 96 : 355 61
9. LaGamba D, Nawshad A, Hay ED. Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 2005 234 : 132 42
10. Huber MA, Azoitei N, Baumann B et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004 114 : 569 81
11. Morali OG, Delmas V, Moore R, Jeanney C, Thiery JP, Larue L. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 2001 20 : 4942 50
12. Woodson K, Flood A, Green L et al. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J Natl Cancer Inst 2004 96 : 407 10
13. Sakatani T, Kaneda A, Iacobuzio-Donahue CA et al. Loss of imprinting of IGF2 alters intestinal maturation and tumorigenesis in mice. Science 2005 307 : 1976 8
14. Bajpai A, Menon S. Insulin like growth factors axis and growth disorders. Indian J Pediatr 2006 73 : 67 71
15. Elkin M, Shevelev A, Schulze E et al. The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Lett 1995 374 : 57 61
16. Rachmilewitz J, Elkin M, Looijenga LH et al. Characterization of the imprinted IPW gene: allelic expression in normal and tumorigenic human tissues. Oncogene 1996 13 : 1687 92
17. Oya M, Schulz WA. Decreased expression of p57 (KIP2) mRNA in human bladder cancer. Br J Cancer 2000 5 : 626 31
18. Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res 2007 67 : 10753 8
19. Li SL, Goko H, Xu ZD et al. Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors. Cell Tissue Res 1998 291 : 469 79
20. Fichera E, Liang S, Xu Z, Guo N, Mineo R, Fujita-Yamaguchi Y. A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues. Growth Horm IGF Res 2000 10 : 61 70
21. Mengual L, Burset M, Ars E et al. Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer. Eur Urol 2006 50 : 1347 56
22. Pavelic K, Bukovic D, Pavelic J. The role of insulin-like growth factor 2 and its receptors in human tumors. Mol Med 2002 8 : 771 80
23. Talwar R, Sinha T, Karan SC et al. Voided urinary cytology in bladder cancer: is it time to review the indications? Urology 2007 70 : 267 71
24. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation toll in clinical medicine. Clin Chem 1993 39 : 561 77
25. Rao G. What is an ROC curve? J Fam Pract 2003 52 : 695